Convergence Investment Partners, LLC Lannett CO Inc Transaction History

Convergence Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$13.3 - $17.45 $436,971 - $573,319	-32,855 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$14.7 - $24.95 $100,768 - $171,032	6,855 Added 26.37%	32,855 $527,000
Q4 2017 Jan 16, 2018	SELL	$19.9 - $29.25 $15,422 - $22,668	-775 Reduced 2.89%	26,000 $603,000
Q3 2017 Nov 13, 2017	BUY	$15.1 - $19.25 $404,302 - $515,418	26,775	26,775 $494,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.